General Information of the Compound
| Compound ID |
CP0393077
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-chloro-4-ethyl-1,4-dihydroquinazolin-2-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-Quinazolinamine, 5-chloro-4-ethyl-1,4-dihydro-
5-Chloro-4-ethyl-1,4-dihydroquinazolin-2-amine
5-chloro-4-ethyl-3,4-dihydroquinazolin-2-amine
918134-92-6
CHEMBL270176
CTK3H8593
DTXSID00659173
SCHEMBL3570857
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H12ClN3
|
||||||||||||||||||
| Molecular Weight |
209.68
|
||||||||||||||||||
| Canonical SMILES |
CCC1NC(N)=Nc2cccc(Cl)c12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H12ClN3/c1-2-7-9-6(11)4-3-5-8(9)14-10(12)13-7/h3-5,7H,2H2,1H3,(H3,12,13,14)
Show/Hide
|
||||||||||||||||||
| InChIKey |
MICIQKQOEFSTDP-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00827, 5-hydroxytryptamine receptor 1D
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT01513, 5-hydroxytryptamine receptor 5A
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Clinical Information about the Compound